Literature DB >> 14512929

Scar-localized argyria secondary to silver sulfadiazine cream.

Nina Myerson Fisher1, Elizabeth Marsh, Rossitza Lazova.   

Abstract

Silver sulfadiazine cream is a topical antibacterial agent that combines the antibacterial effects of both silver and sulfadiazine. Its reported cutaneous side effects include hypersensitivity reactions, allergic contact dermatitis, erythema multiforme, and systemic argyria. We report the case of a patient who had localized argyria develop in a scar after the use of silver sulfadiazine cream. In this case, the silver sulfadiazine cream was applied to and argyria developed within a postsurgical wound and area of severe contact dermatitis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14512929     DOI: 10.1067/s0190-9622(02)61574-9

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  9 in total

1.  Synthesis and antimicrobial studies of silver N-heterocyclic carbene complexes bearing a methyl benzoate substituent.

Authors:  Amanda R Knapp; Matthew J Panzner; Doug A Medvetz; Brian D Wright; Claire A Tessier; Wiley J Youngs
Journal:  Inorganica Chim Acta       Date:  2010-12-15       Impact factor: 2.545

2.  Chemical transformations of nanosilver in biological environments.

Authors:  Jingyu Liu; Zhongying Wang; Frances D Liu; Agnes B Kane; Robert H Hurt
Journal:  ACS Nano       Date:  2012-10-17       Impact factor: 15.881

3.  Internally coated endotracheal tubes with silver sulfadiazine in polyurethane to prevent bacterial colonization: a clinical trial.

Authors:  Lorenzo Berra; Theodor Kolobow; Patrice Laquerriere; Betsey Pitts; Simone Bramati; Joshua Pohlmann; Chiara Marelli; Miriam Panzeri; Pietro Brambillasca; Federico Villa; Andrea Baccarelli; Sylvie Bouthors; Henry T Stelfox; Luca M Bigatello; Joel Moss; Antonio Pesenti
Journal:  Intensive Care Med       Date:  2008-04-17       Impact factor: 17.440

4.  Short term serum pharmacokinetics of diammine silver fluoride after oral application.

Authors:  Elsa Vasquez; Graciela Zegarra; Edgar Chirinos; Jorge L Castillo; Donald R Taves; Gene E Watson; Russell Dills; Lloyd L Mancl; Peter Milgrom
Journal:  BMC Oral Health       Date:  2012-12-31       Impact factor: 2.757

5.  Argyria -- case report.

Authors:  André Lencastre; Maria Lobo; Alexandre João
Journal:  An Bras Dermatol       Date:  2013 May-Jun       Impact factor: 1.896

6.  Label-Free Biosensor Using a Silver Specific RNA-Cleaving DNAzyme Functionalized Single-Walled Carbon Nanotube for Silver Ion Determination.

Authors:  Hui Wang; Yang Liu; Gang Liu
Journal:  Nanomaterials (Basel)       Date:  2018-04-20       Impact factor: 5.076

Review 7.  Clinical and Forensic Aspects of the Different Subtypes of Argyria.

Authors:  Luís Mota; Ricardo Jorge Dinis-Oliveira
Journal:  J Clin Med       Date:  2021-05-13       Impact factor: 4.241

8.  Fate and transformation of silver nanoparticles in different biological conditions.

Authors:  Barbara Pem; Marija Ćurlin; Darija Domazet Jurašin; Valerije Vrček; Rinea Barbir; Vedran Micek; Raluca M Fratila; Jesus M de la Fuente; Ivana Vinković Vrček
Journal:  Beilstein J Nanotechnol       Date:  2021-07-07       Impact factor: 3.649

9.  Exogenous pigmentation by silver nitrate: Dermatological and toxicological aspects, case report

Authors:  Ángela Londoño; Camila Pérez; Rodrigo Restrepo; Nathalie Morales; Miguel Martínez; Daniela Morales
Journal:  Biomedica       Date:  2021-06-29       Impact factor: 0.935

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.